Efficacy and Safety Study of Lamotrigine to Treat Trigeminal Neuralgia

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

21

Participants

Timeline

Start Date

September 30, 2007

Primary Completion Date

February 29, 2008

Study Completion Date

June 30, 2008

Conditions
Trigeminal Neuralgia
Interventions
DRUG

Lamictal®

"The regime of prescription for Lamictal® during the clinical trials was as follows:~1. 50 mg twice daily for 10days, followed by,~2. 100 mg twice daily for the next 10days, followed by,~3. 100 mg thrice daily for the next10 days, followed by,~4. 100 mg four times daily for the final 10 days."

DRUG

Tegretol®

"The regime of prescription for Tegretol® during the clinical trials was as follows:~1. 150 mg twice daily for 10days, followed by,~2. 200 mg thrice daily for the next 10days, followed by,~3. 300 mg thrice daily for the next 10 days, followed by,~4. 300 mg four times daily for the final 10 days."

Trial Locations (2)

50603

Dept. of OMOP, Faculty of Dentistry, University Malaya., Kuala Lumpur

Dept. of Oral Medicine and Oral Pathology, Faculty of Dentistry, University Malaya., Kuala Lumpur

All Listed Sponsors
lead

University of Malaya

OTHER

NCT00913107 - Efficacy and Safety Study of Lamotrigine to Treat Trigeminal Neuralgia | Biotech Hunter | Biotech Hunter